These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6149485)

  • 1. A double-blind clinical evaluation of the effect of Nizofenone (Y-9179) on delayed ischemic neurological deficits following aneurysmal rupture.
    Saito I; Asano T; Ochiai C; Takakura K; Tamura A; Sano K
    Neurol Res; 1983; 5(4):29-47. PubMed ID: 6149485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of nizofenone on the symptomatic vasospasm after aneurysmal subarachnoid hemorrhage and its relationship to the levels of serum complements (CH50, C3 and C4)].
    Ogata N; Yonekawa Y; Kawano T; Tsukahara T
    Nihon Geka Hokan; 1991 Mar; 60(2):135-9. PubMed ID: 1819244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.
    Haley EC; Kassell NF; Torner JC
    J Neurosurg; 1993 Apr; 78(4):537-47. PubMed ID: 8450326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage.
    Tokiyoshi K; Ohnishi T; Nii Y
    Surg Neurol; 1991 Aug; 36(2):112-8. PubMed ID: 1891755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
    Lanzino G; Kassell NF; Dorsch NW; Pasqualin A; Brandt L; Schmiedek P; Truskowski LL; Alves WM
    J Neurosurg; 1999 Jun; 90(6):1011-7. PubMed ID: 10350245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans.
    Thomas JE; Rosenwasser RH
    Neurosurgery; 1999 Jan; 44(1):48-57; discussion 57-8. PubMed ID: 9894963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nizofenone administration in the acute stage following subarachnoid hemorrhage. Results of a multi-center controlled double-blind clinical study.
    Ohta T; Kikuchi H; Hashi K; Kudo Y
    J Neurosurg; 1986 Mar; 64(3):420-6. PubMed ID: 3512795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo.
    Wurm G; Tomancok B; Nussbaumer K; Adelwöhrer C; Holl K
    Clin Neurol Neurosurg; 2004 Mar; 106(2):97-103. PubMed ID: 15003298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study.
    Suzuki S; Sano K; Handa H; Asano T; Tamura A; Yonekawa Y; Ono H; Tachibana N; Hanaoka K
    Neurol Res; 1989 Jun; 11(2):79-88. PubMed ID: 2569686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine.
    Philippon J; Grob R; Dagreou F; Guggiari M; Rivierez M; Viars P
    Acta Neurochir (Wien); 1986; 82(3-4):110-4. PubMed ID: 3538789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
    J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial.
    Shibuya M; Suzuki Y; Sugita K; Saito I; Sasaki T; Takakura K; Nagata I; Kikuchi H; Takemae T; Hidaka H
    J Neurosurg; 1992 Apr; 76(4):571-7. PubMed ID: 1545249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain protection against ischemic injury by nizofenone.
    Yasuda H; Nakajima A
    Cerebrovasc Brain Metab Rev; 1993; 5(4):264-76. PubMed ID: 8110594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH.
    Hendryk S; Jarzab B; Josko J
    Neuro Endocrinol Lett; 2004; 25(1-2):141-7. PubMed ID: 15159698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The angiographical study on cerebral vasospasm following the rupture of intracranial aneurysm (1st report).--Time relationship between vasospasm on angiography and the onset of subarachnoid hemorrhage (aurhor's transl)].
    Niizuma H; Kwak R; Ohi T; Katakura R; Mizoi K; Suzuki J
    No Shinkei Geka; 1978 Aug; 6(8):749-55. PubMed ID: 724078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage.
    McGirt MJ; Blessing R; Nimjee SM; Friedman AH; Alexander MJ; Laskowitz DT; Lynch JR
    Neurosurgery; 2004 Jun; 54(6):1369-73; discussion 1373-4. PubMed ID: 15157293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral vasospasm and calcium channel blockade. Nimodipine treatment in patients with aneurysmal subarachnoid hemorrhage.
    Brandt L; Ljunggren B; Säveland H; Andersson KE; Vinge E
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():151-5. PubMed ID: 3521193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial.
    Petruk KC; West M; Mohr G; Weir BK; Benoit BG; Gentili F; Disney LB; Khan MI; Grace M; Holness RO
    J Neurosurg; 1988 Apr; 68(4):505-17. PubMed ID: 3280746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Matsuda N; Naraoka M; Ohkuma H; Shimamura N; Ito K; Asano K; Hasegawa S; Takemura A
    Cerebrovasc Dis; 2016; 42(1-2):97-105. PubMed ID: 27070952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.